Lliac artery stenting shows good long-term results

Article

Endovascular stenting as the initial treatment for patients with occluded iliac arteries has been shown to be both safe and cost-effective by more than five years of follow-up in the Dutch Iliac Stent Trial.

Endovascular stenting as the initial treatment for patients with occluded iliac arteries has been shown to be both safe and cost-effective by more than five years of follow-up in the Dutch Iliac Stent Trial.

Dr. Willemijn M. Klein and colleagues retrospectively reviewed 143 patients who underwent primary stent placement and 136 who underwent primary angioplasty followed by selective stent placement. They found no statistically significant difference between the two groups in the number of reinterventions, additional cardiovascular events, or mortality.

The real danger for these patients is cardiovascular complications leading to fatal episodes, according to a study in the August issue of Radiology. Peripheral artery disease should thus be considered a marker of potentially dangerous atherosclerotic disease elsewhere in the body, the researchers said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.